Skip to main content
OpenTrials
Completed

NCT Number: NCT01654198

PET/CT in Psoriatic Arthritis

When patients with psoriasis develop joint pain, it is often hard to decide whether or not the pain is due to psoriatic arthritis (PsA). At this time, doctors use information from the history and physical exam to determine the diagnosis. X-rays, magnetic resonance imaging (MRI) and ultrasound have been used to help with the diagnosis but all three have limitations. A newer imaging technique, whole body Positron Emission Tomography/Computed Tomography (PET/CT) uses the idea that inflammatory cells take up sugar to locate inflammation in the body. Because patients with PsA have inflammatory cells in their joints and tendons, this type of scan allows the physician to take a picture of the whole body and locate inflammation. The investigators have found that some patients with psoriasis (but without arthritis) have inflammation in joints and tendons even before the patient has symptoms. In this study, the investigators will explore how well PET/CT works for assessing inflammation in patients with PsA. This would be a very exciting tool that could be used to find and treat inflammation before it causes damage or pain.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Pennsylvania Division of Rheumatology

Philadelphia, Pennsylvania, 19104, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18-80,
  • active psoriatic arthritis (joint or enthesis inflammation)

Exclusion criteria

  • Diabetes,
  • pregnant,
  • no active PsA

Treatment and study plan

FDG-PET/CT scan

Radiation

FDG-PET/CT is a type of imaging used currently to look for cancer. We are using it to look at inflammation within the joints.

Primary outcomes

  1. Primary outcome is inflammation as measured by SUVmax and metabolic volumetric product in the joints and entheses.

    Time frame: At the discretion of the PI

Secondary outcomes

  1. Correlation of local inflammation in joints and enthesis with systemic inflammatory markers including IL6 and high sensitivity CRP.

    Time frame: At the discretion of the PI

Sponsors and collaborators

Lead sponsor

University of Pennsylvania

Other

Registry information

Official study title

FDG-PET/CT in the Diagnosis and Monitoring of Psoriatic Arthritis

Important dates

Study start
2012
Primary completion
2018
Study completion
2018
First posted
Jul 31, 2012
Registry last updated
Dec 8, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.